FOXO1 and leukemia: In the specimens of MDS patients, we further verified that with the increased expression of FOXO1, there is a wide range of upregulation and activation of type I immune cell transcription factors and up-regulation of cellular immune functions, thereby enhancing anti-leukemia effects and inhibiting the growth of MDS malignant clones.